Skip to main content
Premium Trial:

Request an Annual Quote

Lee McCracken

Molecular Diagnostics has appointed Lee McCracken to its board of directors. In 2014, McCracken was appointed CEO of Gensignia Life Sciences. Previously, he held positons as president and CEO of Pathwork Diagnostics. Before that, McCracken served as corporate head of business development at Prometheus Laboratories, senior vice president of pharma business development at Diversa (merged with Verenium), president and chief business officer of GenStar Therapeutics, and senior vice president of corporate development at CombiChem (acquired by DuPont Pharmaceuticals).